查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356797

先天性肾上腺增生症诊断市场报告：2030 年趋势、预测与竞争分析

Congenital Adrenal Hyperplasia Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

先天性肾上腺增生症的诊断趋势与预测

预计到 2030 年，全球先天性肾上腺增生症诊断市场将达到 8 亿美元，2024 年至 2030 年年复合成长率为 7.7%。该市场的主要驱动因素是先天性肾上腺增生症的上升、政府资助和临床试验、医疗保健政策和报销的增加以及基因检测技术进步的增加。全球先天性肾上腺增生症诊断市场的未来前景广阔，医院、诊断中心、门诊手术中心和诊所市场都有商机。

先天性肾上腺增生症诊断市场洞察

Lucintel 预测，由于医疗保健专业人员、患者和公众对 CAH 的认识和教育不断提高，典型的先天性肾上腺增生症将在预测期内经历高速增长。

医院可能仍然是最大的细分市场，因为人们越来越倾向于医院护理，因为医院可以轻鬆获得良好的管理设施并受益于广泛的基础设施。

由于存在大量患者、人们对罕见遗传疾病的认识不断提高以及医疗基础设施的改善，预计亚太地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球先天性肾上腺增生症诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球先天性肾上腺增生症诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球先天性肾上腺增生症诊断市场
    • 典型的先天性肾上腺增生症
    • 非典型先天性肾上腺增生症
  • 以最终用途分類的全球先天性肾上腺增生症诊断市场
    • 医院
    • 诊断中心
    • 门诊手术中心
    • 诊所
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球先天性肾上腺增生症诊断市场（按地区）
  • 北美先天性肾上腺增生症诊断市场
  • 欧洲先天性肾上腺增生症诊断市场
  • 亚太地区先天性肾上腺增生症诊断市场
  • 其他区域先天性肾上腺增生症诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球先天性肾上腺增生症诊断市场成长机会
    • 按最终用途分類的全球先天性肾上腺增生症增生诊断市场的成长机会
    • 全球先天性肾上腺增生症诊断市场按地区成长机会
  • 全球先天性肾上腺增生症诊断市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球先天性肾上腺增生症诊断市场的产能扩张
    • 全球先天性肾上腺增生症诊断市场的合併、收购及合资企业
    • 认证和许可

第7章主要企业概况

  • Medline Industries
  • Cook Medical
  • Cooper Surgical
  • Smiths Medical
  • Becton, Dickinson and Company
  • Rocket Medical
  • CENTOGENE NV
  • Eurofins Scientific
  • PerkinElmer
  • F. Hoffmann-La Roche.
简介目录

Congenital Adrenal Hyperplasia Diagnosis Trends and Forecast

The future of the global congenital adrenal hyperplasia diagnosis market looks promising with opportunities in the hospital, diagnostic center, ambulatory surgical center, and clinic markets. The global congenital adrenal hyperplasia diagnosis market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 7.7% from 2024 to 2030. The major drivers for this market are rising prevalence of congenital adrenal hyperplasia, growing government funding and clinical trials, and healthcare policies and reimbursement and increasing technological advancements in genetic testing.

A more than 150-page report is developed to help in your business decisions.

Congenital Adrenal Hyperplasia Diagnosis by Segment

The study includes a forecast for the global congenital adrenal hyperplasia diagnosis by type, end use, and region.

Congenital Adrenal Hyperplasia Diagnosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Classic Congenital Adrenal Hyperplasia
  • Non-classic Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Congenital Adrenal Hyperplasia Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Congenital Adrenal Hyperplasia Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies congenital adrenal hyperplasia diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the congenital adrenal hyperplasia diagnosis companies profiled in this report include-

  • Medline Industries
  • Cook Medical
  • Cooper Surgical
  • Smiths Medical
  • Becton, Dickinson And Company
  • Rocket Medical
  • Centogene N.V
  • Eurofins Scientific
  • Perkinelmer
  • F. Hoffmann-La Roche.

Congenital Adrenal Hyperplasia Diagnosis Market Insights

Lucintel forecasts that classic congenital adrenal hyperplasia is expected to witness higher growth over the forecast period due to growing awarness and education towards CAH among medical professionals, patients, and general public.

Hospitals will remain the largest segment due to increasing inclination towards hospital-based treatments, where they can easily access superior management facilities and benefit from enhanced infrastructure.

APAC is expected to witness highest growth over the forecast period due to presence of large pool of patients, increasing awareness towards rare genetic disorders, and improving healthcare infrastructure in the region.

Features of the Global Congenital Adrenal Hyperplasia Diagnosis Market

Market Size Estimates: Congenital adrenal hyperplasia diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Congenital adrenal hyperplasia diagnosis market size by type, end use, and region. in terms of value ($B).

Regional Analysis: Congenital adrenal hyperplasia diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the congenital adrenal hyperplasia diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the congenital adrenal hyperplasia diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the congenital adrenal hyperplasia diagnosis market size?

Answer: The global congenital adrenal hyperplasia diagnosis market is expected to reach an estimated $0.8 billion by 2030.

Q.2. What is the growth forecast for congenital adrenal hyperplasia diagnosis market?

Answer: The global congenital adrenal hyperplasia diagnosis market is expected to grow with a CAGR of 7.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the congenital adrenal hyperplasia diagnosis market?

Answer: The major drivers for this market are rising prevalence of congenital adrenal hyperplasia, growing government funding and clinical trials, and healthcare policies and reimbursement and increasing technological advancements in genetic testing.

Q.4. What are the major segments for congenital adrenal hyperplasia diagnosis market?

Answer: future of the global congenital adrenal hyperplasia diagnosis market looks promising with opportunities in the hospital, diagnostic center, ambulatory surgical center, and clinic markets.

Q.5. Who are the key congenital adrenal hyperplasia diagnosis market companies?

Answer: Some of the key congenital adrenal hyperplasia diagnosis companies are as follows:

  • Medline Industries
  • Cook Medical
  • Cooper Surgical
  • Smiths Medical
  • Becton, Dickinson and Company
  • Rocket Medical
  • CENTOGENE N.V
  • Eurofins Scientific
  • PerkinElmer
  • F. Hoffmann-La Roche.

Q.6. Which congenital adrenal hyperplasia diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that classic congenital adrenal hyperplasia is expected to witness higher growth over the forecast period due to growing awarness and education towards CAH among medical professionals, patients, and general public.

Q.7. In congenital adrenal hyperplasia diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to substantial patient population, the increasing incidence of congenital adrenal hyperplasia, well-established hospitals and health care infrastructure, and robust governmental backing for R&D initiatives. APAC is expected to witness highest growth over the forecast period due to presence of large pool of patients, increasing awareness towards rare genetic disorders, and improving healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the congenital adrenal hyperplasia diagnosis market by type (classic congenital adrenal hyperplasia and non-classic congenital adrenal hyperplasia), end use (hospitals, diagnostic centers, ambulatory surgical centers, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Congenital Adrenal Hyperplasia Diagnosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Congenital Adrenal Hyperplasia Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Congenital Adrenal Hyperplasia Diagnosis Market by Type
    • 3.3.1: Classic Congenital Adrenal Hyperplasia
    • 3.3.2: Non-classic Congenital Adrenal Hyperplasia
  • 3.4: Global Congenital Adrenal Hyperplasia Diagnosis Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Diagnostic Centers
    • 3.4.3: Ambulatory Surgical Centers
    • 3.4.4: Clinics
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Congenital Adrenal Hyperplasia Diagnosis Market by Region
  • 4.2: North American Congenital Adrenal Hyperplasia Diagnosis Market
    • 4.2.2: North American Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
  • 4.3: European Congenital Adrenal Hyperplasia Diagnosis Market
    • 4.3.1: European Congenital Adrenal Hyperplasia Diagnosis Market by Type: Classic Congenital Adrenal Hyperplasia and Non-classic Congenital Adrenal Hyperplasia
    • 4.3.2: European Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
  • 4.4: APAC Congenital Adrenal Hyperplasia Diagnosis Market
    • 4.4.1: APAC Congenital Adrenal Hyperplasia Diagnosis Market by Type: Classic Congenital Adrenal Hyperplasia and Non-classic Congenital Adrenal Hyperplasia
    • 4.4.2: APAC Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
  • 4.5: ROW Congenital Adrenal Hyperplasia Diagnosis Market
    • 4.5.1: ROW Congenital Adrenal Hyperplasia Diagnosis Market by Type : Classic Congenital Adrenal Hyperplasia, and Non-classic Congenital Adrenal Hyperplasia
    • 4.5.2: ROW Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by Type
    • 6.1.2: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by End Use
    • 6.1.3: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by Region
  • 6.2: Emerging Trends in the Global Congenital Adrenal Hyperplasia Diagnosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Congenital Adrenal Hyperplasia Diagnosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Congenital Adrenal Hyperplasia Diagnosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medline Industries
  • 7.2: Cook Medical
  • 7.3: Cooper Surgical
  • 7.4: Smiths Medical
  • 7.5: Becton, Dickinson and Company
  • 7.6: Rocket Medical
  • 7.7: CENTOGENE N.V
  • 7.8: Eurofins Scientific
  • 7.9: PerkinElmer
  • 7.10: F. Hoffmann-La Roche.